For the latest ecancer COVID-19 resources, click on this link

Breast

Prostate & urology

Lung & pleura

Colorectal & gastro

Melanoma & skin

Head & neck

Ovary & gynaecology

+ -

Spanish Lung Cancer Group

ESMO 33

12 - 16 Sep 2008

Published: 3 Dec 2008

Views: 15813

Rating:

Save

Prof. Rafael Rosel

Benefits of customising erlotinib therapy for NSCLC.

Categories:
Lung & pleura

Related Videos

Efficacy and safety of patritumab deruxtecan (HER3-DXd) in EGFR inhibitor-resist...

Dr. Christina Baik - University of Washington School of Medicine, Seattle, USA

Efficacy and safety of patritumab deruxtecan (HER3-DXd) in EGFR inhibitor-resistant, EGFR-mutated non-small cell lung cancer ( Dr. Christina Baik - University of Washington School of Medicine, Seattle, USA )

Optimal patient management with the use of immunotherapies in lung cancer

Dr Antonio Passaro, Prof Heather Wakelee, Dr Jessica Donington, Prof Sanjay Popa...

Optimal patient management with the use of immunotherapies in lung cancer ( Dr Antonio Passaro, Prof Heather Wakelee, Dr Jessica Donington, Prof Sanjay Popat and Prof Martin Reck )

IMpower010: Atezolizumab versus best supportive care after adjuvant chemotherapy...

Prof Heather Wakelee - Stanford University, Stanford, USA

IMpower010: Atezolizumab versus best supportive care after adjuvant chemotherapy in resected NSCLC ( Prof Heather Wakelee - Stanford University, Stanford, USA )

CodeBreaK100 trial: Evaluating Sotorasib in pretreated KRAS p.G12C mNSCLC

Dr Ferdinandos Skoulidis - MD Anderson Cancer Center, Houston, USA

CodeBreaK100 trial: Evaluating Sotorasib in pretreated KRAS p.G12C mNSCLC ( Dr Ferdinandos Skoulidis - MD Anderson Cancer Center, Houston, USA )

Amivantamab in combination with lazertinib for osimertinib-relapsed, chemo-naïve...

Dr Joshua Sabari and Dr Anna Minchom

Amivantamab in combination with lazertinib for osimertinib-relapsed, chemo-naïve EGFRm NSCLC ( Dr Joshua Sabari and Dr Anna Minchom )

NIVO plus chemo vs chemo alone as neoadjuvant treatment for patients with resect...

Dr Jonathan Spicer - McGill University, Montreal, Canada

NIVO plus chemo vs chemo alone as neoadjuvant treatment for patients with resectable NSCLC ( Dr Jonathan Spicer - McGill University, Montreal, Canada )

OncoAlert and ecancer weekly roundup for April 26 - May 3, 2021

Dr Gil Morgan - Skåne University Hospital in Lund, Sweden

OncoAlert and ecancer weekly roundup for April 26 - May 3, 2021 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )

UpSwinG: Real-world, non-interventional cohort study on TKI activity in patients...

Dr Satoru Miura - Niigata Cancer Center Hospital, Niigata, Japan

UpSwinG: Real-world, non-interventional cohort study on TKI activity in patients with EGFRm NSCLC with uncommon mutations ( Dr Satoru Miura - Niigata Cancer Center Hospital, Niigata, Japan )

PIPSeN trial: Olaparib maintenance vs placebo in platinum-sensitive non-small ce...

Dr Sophie Postel-Vinay - Gustave Roussey Cancer Center, Paris, France

PIPSeN trial: Olaparib maintenance vs placebo in platinum-sensitive non-small cell lung cancer ( Dr Sophie Postel-Vinay - Gustave Roussey Cancer Center, Paris, France )

More from ecancer